Movers: Genetic Technologies, Progenics Pharmaceuticals, Repros Therapeutics, Tekmira Pharmaceuticals, Threshold Pharmaceuticals Print E-mail
Monday, 22 September 2014 13:42
U.S. stocks fell on Monday, with the Dow Jones Industrial Average stepping back from an all-time high, as uncertainty about China's growth injected caution into global markets. Stocks' cautious tone began overnight, after China's financial minister said that major changes to the country's economic stimulus efforts aren't likely even as the world's second-largest economy grapples with growth concerns.
Read more...
 
ACCESS PHARMACEUTICALS ANNOUNCES EXCLUSIVE GLOBAL PLASMA THERAPEUTICS LICENSE, NEW MANAGEMENT AND NEW CORPORATE NAME Print E-mail
Monday, 22 September 2014 09:47
Name Changed to PlasmaTech Biopharmaceuticals, Inc.   Proprietary, Disruptive Technology for the Bioidentical Therapeutics Business   Dallas, TX and New York, NY, September 22, 2014 - ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), has signed an exclusive, global license agreement with Plasma Technologies LLC ("PlasmaTech") for the development and commercialization of its proprietary plasma fractionation process.
Read more...
 
RELMADA THERAPEUTICS, INC. APPOINTS CHRISTOPHER W. JAMES AS SENIOR DIRECTOR OF CLINICAL DEVELOPMENT Print E-mail
Thursday, 18 September 2014 19:04
New York, NY--Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Mr. Christopher W. James to the position of  Senior Director of Clinical Development.
Read more...
 
Newsmakers: Delcath Systems, ImmunoCellular Therapeutics, Oncolytics Biotech, Concert Pharmaceuticals, CTI BioPharma Print E-mail
Wednesday, 17 September 2014 14:28
Stocks rose and bonds held steady, as investors were reassured by the prospect of low interest rates for a while longer.
Read more...
 
Newsmakers: MediciNova, PharmAthene, Rewalk Robotics, Avanir Pharmaceuticals, Northwest Biotherapeutics Print E-mail
Tuesday, 16 September 2014 14:21
U.S. stocks gained as investors weighed the likelihood that the Federal Reserve will continue to emphasize low interest rates coming out of its policy-setting meeting Wednesday.
Read more...
 
Newsmakers: Alere Inc, ImmunoGen, Avanir Pharmaceuticals, Rewalk Robotics, Meridian Bioscience Print E-mail
Monday, 15 September 2014 14:17
U.S. stocks were mixed on Monday with the tech sector weighing on the Nasdaq and S&P 500 as investors make space for Alibaba's planned debut later this week.
Read more...
 
Newsmakers: Misonix, Cardinal Health, Orexigen Therapeutics, Aastrom Biosciences, Achillion Pharmaceuticals Print E-mail
Thursday, 11 September 2014 16:29
U.S. stocks traded lower at midday on Thursday as energy shares continued to fall and shares of Apple dipped.
Read more...
 
Movers: RXi Pharmaceuticals, Avanir Pharmaceuticals, Seattle Genetics, PharmAthene, NPS Pharmaceuticals Print E-mail
Wednesday, 10 September 2014 16:13
U.S. stocks jumped on Wednesday, recovering from two days of losses for the broad market.
Read more...
 
Newsmakers: Keryx Biopharmaceuticals, Merus Labs International, Hemispherx BioPharma, GlaxoSmithKline plc, Mast Therapeutics Print E-mail
Monday, 08 September 2014 13:55
U.S. stocks fell in afternoon trading Monday, on profit booking following gains last week.
Read more...
 
Movers: Stellar Biotechnologies, Chimerix Inc, Stereotaxis Inc, Depomed Inc, Aradigm Corporation Print E-mail
Thursday, 04 September 2014 14:47
The Dow Jones Industrial Average made another record in intraday session following the European Central Bank's surprise interest-rate cut helped boost stocks.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 10 of 12

Newsletter